skip to Main Content

 

Overview of the Digital Competition Bill


Overview of the Indian Commitment and Settlement Regime


Key features of the Turnover Regulations and Penalty Guidelines


Changes to the Monetary Thresholds that Trigger Merger Notifications


CCI’s Revamped Leniency Regime Goes Live


Responsible Lending Conduct – Time bound release of Property Documents on loan closure


Erase and Rewind: Data Protection in India | Digital Personal Data Protection Bill, 2023


Provisions Of The Competition (Amendment) Act, 2023 Come Into Effect


IRDAI (Registration of Indian Insurance Companies) Regulations, 2022 and the Master Circular on Registration of Indian Insurance Company, 2023: Revamped regulatory regime


LIBOR Transition in the Indian financial system


Digital Personal Data Protection Bill, 2022


Key Components of a Non-Disclosure Agreement


Competition Commission passes two orders against Google for abuse of dominance and imposes collective fine of INR 2,274 crore


Drugs and Cosmetics Act, 1940 – Madras High Court holds that all the directors of a pharmaceutical company will be vicariously liable for the production / manufacture of sub-standard drugs and fastens criminal liability on them


Stalling tender processes


Overhauling the Confidentiality Rules


The rise of foreign investment in Indian real estate


Impact of COVID 19 on the Pharmaceutical Industry in India


Commercial Disputes: Supreme Court declares that pre-institution mediation and settlement is mandatory for disputes filed under the Commercial Courts Act, 2015 where no urgent interim reliefs is sought failing which the plaint must be rejected


Prevention of Money Laundering Act, 2002: SC upholds validity of the stringent twin-conditions for bail amongst other provisions and says it is enough if Enforcement Directorate discloses grounds at the time of arrest


Elements of a Privacy Policy in India


ESG Disclosures for Indian Companies


Pharmaceutical Regulations: Central Government forms a Five-Member Committee to review marketing practices of pharmaceutical companies

Back To Top
Search

DISCLAIMER

The Bar Council of India does not permit soliciting work or advertising by advocates in any manner or form. By clicking on "AGREE" below, the user acknowledges and confirms that:

  1. There has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from us or any of our members to solicit any work through this website;
  2. The website is a resource solely for the purpose of providing general information about Veritas Legal at the user’s own risk, cost and liability; 
  3. The information provided in this website shall not be construed as legal advice or create any lawyer-client relationship in any manner whatsoever; 
  4. The links provided on this website shall in no way be considered referrals, endorsements or affiliations with the linked entities and Veritas Legal shall not hold responsibility for the content of such links.

The user shall not hold Veritas Legal responsible for any action taken relying upon the content of the website. In cases where the user has any legal issues and requires assistance, he/she/it must seek independent legal advice.